Skip to main content

COVID-19 Resources

What people with cancer should know:

Guidance for cancer researchers:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Grant Details

Grant Number: 5R01CA114534-03 Interpret this number
Primary Investigator: Schernhammer, Eva
Organization: Brigham And Women'S Hospital
Project Title: Clock Genes, Night Work, and Breast Cancer Risk
Fiscal Year: 2008


Light exposure at night may have an adverse effect on breast cancer risk through suppression of melatonin, a hormone that is intimately linked to the circadian system and demonstrates cancer-protective effects. Observational studies have consistently associated night work with an increase in breast cancer risk. To date, nine candidate genes for human circadian dysrhythmias have been identified, and common mutations of four of those were associated with seasonal affective disorder, familial advanced sleep phase syndrome, and diurnal preference. In mice, loss of mPer2 function results in increased tumor development and deficiencies in DMAdamage responses. In humans, data, although still sparse, indicate a positive association between certain clock gene mutations and breast cancer risk. Thus, future investigations of the associations between breast cancer risk and circadian disruption, such as experienced by night workers, must take into consideration the role of clock genes. In this study, we propose to draw on the existing data and DMAsamples from the ongoing Nurses Health Study II (NHS II) to conduct a nested case-control study that evaluates associations of common variants in candidate genes of the circadian clock with breast cancer risk, as well as interactions with night shift work. We will assess how the nurses' breast cancer risk is influenced by different polymorphisms of clock genes and will characterize differences in these associations according to night work status of nurses. To further study the relationship between molecular rhythmicity and other markers of the circadian system, we will also assess the association of these genes with variations in melatonin levels. No other prospective cohort study can provide superior resources to answer these questions: in the NHSII cohort study, night shift work status has been assessed biennially from 1989 onwards, melatonin levels have been measured in a subgroup of women, and an extensive collection of DNA is currently under way that will provide DNA from 1,108 breast cancer cases and their 1:3 matched controls. The results from this study could help identify individuals who are more susceptible to night work than others, based on their genetic profile.


Total and cause-specific mortality of U.S. nurses working rotating night shifts.
Authors: Gu F. , Han J. , Laden F. , Pan A. , Caporaso N.E. , Stampfer M.J. , Kawachi I. , Rexrode K.M. , Willett W.C. , Hankinson S.E. , et al. .
Source: American journal of preventive medicine, 2015 Mar; 48(3), p. 241-52.
EPub date: 2015-01-06.
PMID: 25576495
Related Citations

Circadian genes and breast cancer susceptibility in rotating shift workers.
Authors: Monsees G.M. , Kraft P. , Hankinson S.E. , Hunter D.J. , Schernhammer E.S. .
Source: International journal of cancer, 2012-12-01; 131(11), p. 2547-52.
EPub date: 2012-09-07.
PMID: 22473669
Related Citations

Circulating melatonin and the risk of breast and endometrial cancer in women.
Authors: Viswanathan A.N. , Schernhammer E.S. .
Source: Cancer letters, 2009-08-18; 281(1), p. 1-7.
EPub date: 2008-12-12.
PMID: 19070424
Related Citations

Back to Top